Ionizing radiation biomarkers for potential use in epidemiological studies

Eileen Pernot, Janet Hall, Sarah Baatout, Rafi Benotmane, Eric Blanchardon, Simon Bouffler, Houssein El Saghire, Maria Gomolka, Anne Guertler, Mats Harms-Ringdahl, Penny Jeggo, Michaela Kreuzer, Dominique Laurier, Carita Lindholm, Radhia Mkacher, Roel Quintens, Kai Rothkamm, Laure Sabatier, Soile Tapio, Florent de VathaireElisabeth Cardis, Hans Vanmarcke

    Research outputpeer-review


    Ionizing radiation is a known human carcinogen that can induce a variety of biological effects depending on the physical nature, duration, doses and dose-rates of exposure. However, the magnitude of health risks at low doses and dose-rates (below 100 mSv and/or 0.1 mSv min_1) remains controversial due to a lack of direct human evidence. This review summarises the multidisciplinary work to identify the most appropriate biomarkers for use in population studies. In addition to logistical and ethical considerations for conducting large-scale epidemiological studies, we discuss the relevance of their use for assessing the effects of low dose ionizing radiation exposure at the cellular and physiological level. We also propose a temporal classification of biomarkers that may be relevant for molecular epidemiology studies which need to take into account the time elapsed since exposure. Finally, the integration of biology with epidemiology requires careful planning and enhanced discussions between the epidemiology, biology and dosimetry communities in order to determine the most important questions to be addressed in light of pragmatic considerations including the appropriate population to be investigated (occupationally, environmentally or medically exposed), and study design.
    Original languageEnglish
    Pages (from-to)258-286
    JournalMutation Research/Reviews in Mutation Research
    Issue number2
    StatePublished - Oct 2012

    Cite this